6 research outputs found
ΠΠ΅ΡΠ΅ΠΊΠΈΡΠ½ΠΎΠ΅ ΠΎΠΊΠΈΡΠ»Π΅Π½ΠΈΠ΅ Π»ΠΈΠΏΠΈΠ΄ΠΎΠ² ΠΏΡΠΈ ΡΠ΅ΡΠ΅ΠΏΠ½ΠΎ-ΠΌΠΎΠ·Π³ΠΎΠ²ΠΎΠΉ ΡΡΠ°Π²ΠΌΠ΅ (ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅)
Objective: to study the general mechanisms responsible for the formation and stepwise development of the endogenous intoxication syndrome in the injury. Material and methods. One hundred and thirty animals with experimental brain injury (a blow upon the calvarium delivered by a free weight falling) were examined to study the pro- and antioxidant systems, the enzymatic activity in the blood and brain tissue homogenates; the markers of endogenous intoxication, such as medium-weight molecules, were determined. According to the neurological deficit scale developed by A. Ya. Yevtushenko (1989), the animals were divided into 2 groups: 1) those with a good (compensated) posttraumatic course and 2) those with a poor (decompensated) one. A package of the applied statistical programs Β«STADIA.6.1/profΒ» and Β«STATISTIKAΒ» was employed. Results. Brain injury was used as an example to show how the posttraumatic endogenous intoxication syndrome developed. The latter developed on the cascade principle with the stepwise involvement of the homeostatic systems and with the more aggravated injury. The syndrome is determined by the initiation of processes of lipid peroxidation with the accumulation of its products and by the exhausted spares of antioxidant systems. This leads to hyperenzymemia (the enhanced activity of cathepsin D, acid phosphatase in the brain tissues and blood) and to the blood accumulation of toxic substances (medium-weight molecules) (toxemia). Key words: posttraumatic endogenous intoxication syndrome, lipid peroxidation, brain injury.Π¦Π΅Π»Ρ β ΠΈΠ·ΡΡΠΈΡΡ ΠΎΠ±ΡΠΈΠ΅ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΡ ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΈ ΡΡΠ°ΠΏΠ½ΠΎΡΡΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° ΡΠ½Π΄ΠΎΠ³Π΅Π½Π½ΠΎΠΉ ΠΈΠ½ΡΠΎΠΊΡΠΈΠΊΠ°ΡΠΈΠΈ ΠΏΡΠΈ ΡΡΠ°Π²ΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΠΈ. ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. Π£ 130 ΠΆΠΈΠ²ΠΎΡΠ½ΡΡ
Ρ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ΅ΠΏΠ½ΠΎ-ΠΌΠΎΠ·Π³ΠΎΠ²ΠΎΠΉ ΡΡΠ°Π²ΠΌΠΎΠΉ (ΠΎΠ΄ΠΈΠ½ ΡΠ΄Π°Ρ ΠΏΠΎ ΡΠ²ΠΎΠ΄Ρ ΡΠ΅ΡΠ΅ΠΏΠ° ΡΠ²ΠΎΠ±ΠΎΠ΄Π½ΠΎ ΠΏΠ°Π΄Π°ΡΡΠΈΠΌ Π³ΡΡΠ·ΠΎΠΌ) ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π»ΠΈ ΡΠΎΡΡΠΎΡΠ½ΠΈΠ΅ ΠΏΡΠΎ- ΠΈ Π°Π½ΡΠΈΠΎΠΊΡΠΈΠ΄Π°Π½ΡΠ½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌ, Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΡΠ΅ΡΠΌΠ΅Π½ΡΠΎΠ² Π² ΠΊΡΠΎΠ²ΠΈ ΠΈ Π³ΠΎΠΌΠΎΠ³Π΅Π½Π°ΡΠ°Ρ
ΡΠΊΠ°Π½ΠΈ Π³ΠΎΠ»ΠΎΠ²Π½ΠΎΠ³ΠΎ ΠΌΠΎΠ·Π³Π°; ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»ΠΈ ΠΌΠ°ΡΠΊΠ΅ΡΡ ΡΠ½Π΄ΠΎΠ³Π΅Π½Π½ΠΎΠΉ ΠΈΠ½ΡΠΎΠΊΡΠΈΠΊΠ°ΡΠΈΠΈ β ΠΌΠΎΠ»Π΅ΠΊΡΠ»Ρ ΡΡΠ΅Π΄Π½Π΅ΠΉ ΠΌΠ°ΡΡΡ. ΠΠΎ ΡΠΊΠ°Π»Π΅ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ Π½Π΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π΄Π΅ΡΠΈΡΠΈΡΠ° Π. Π―. ΠΠ²ΡΡΡΠ΅Π½ΠΊΠΎ (1989) ΠΆΠΈΠ²ΠΎΡΠ½ΡΠ΅ Π±ΡΠ»ΠΈ ΡΠ°Π·Π΄Π΅Π»Π΅Π½Ρ Π½Π° Π΄Π²Π΅ Π³ΡΡΠΏΠΏΡ: 1-Ρ β Ρ Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΡΠΌ (ΠΊΠΎΠΌΠΏΠ΅Π½ΡΠΈΡΠΎΠ²Π°Π½Π½ΡΠΌ) ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΏΠΎΡΡΡΡΠ°Π²ΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΠ΅ΡΠΈΠΎΠ΄Π° ΠΈ 2-Ρ β Ρ Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΡΠΌ (Π΄Π΅ΠΊΠΎΠΌΠΏΠ΅Π½ΡΠΈΡΠΎΠ²Π°Π½Π½ΡΠΌ) ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ. ΠΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π»ΠΈ ΠΏΠ°ΠΊΠ΅Ρ ΠΏΡΠΈΠΊΠ»Π°Π΄Π½ΡΡ
ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌ Β«STADIA. 6.1/profΒ», Β«STATISTIKAΒ». Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠ° ΠΏΡΠΈΠΌΠ΅ΡΠ΅ ΡΠ΅ΡΠ΅ΠΏΠ½ΠΎ-ΠΌΠΎΠ·Π³ΠΎΠ²ΠΎΠΉ ΡΡΠ°Π²ΠΌΡ ΠΏΠΎΠΊΠ°Π·Π°Π½Ρ Π·Π°ΠΊΠΎΠ½ΠΎΠΌΠ΅ΡΠ½ΠΎΡΡΠΈ ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° ΠΏΠΎΡΡΡΡΠ°Π²ΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ½Π΄ΠΎΠ³Π΅Π½Π½ΠΎΠΉ ΠΈΠ½ΡΠΎΠΊΡΠΈΠΊΠ°ΡΠΈΠΈ. Π‘ΠΈΠ½Π΄ΡΠΎΠΌ ΡΠ°Π·Π²ΠΈΠ²Π°Π΅ΡΡΡ ΠΏΠΎ ΠΊΠ°ΡΠΊΠ°Π΄Π½ΠΎΠΌΡ ΠΏΡΠΈΠ½ΡΠΈΠΏΡ Ρ ΠΏΠΎΡΡΠ°ΠΏΠ½ΡΠΌ Π²ΠΎΠ²Π»Π΅ΡΠ΅Π½ΠΈΠ΅ΠΌ ΡΠΈΡΡΠ΅ΠΌ Π³ΠΎΠΌΠ΅ΠΎΡΡΠ°Π·Π° ΠΈ ΡΡΡΠ³ΡΠ±Π»Π΅Π½ΠΈΠ΅ΠΌ ΡΡΠΆΠ΅ΡΡΠΈ ΡΠ΅ΡΠ΅Π½ΠΈΡ ΡΡΠ°Π²ΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΠΈ. ΠΠ³ΠΎ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ΅Ρ Π·Π°ΠΏΡΡΠΊ ΠΏΡΠΎΡΠ΅ΡΡΠΎΠ² Π»ΠΈ-ΠΏΠΎΠΏΠ΅ΡΠΎΠΊΡΠΈΠ΄Π°ΡΠΈΠΈ Ρ Π½Π°ΠΊΠΎΠΏΠ»Π΅Π½ΠΈΠ΅ΠΌ ΠΏΡΠΎΠ΄ΡΠΊΡΠΎΠ² ΠΏΠ΅ΡΠ΅ΠΊΠΈΡΠ½ΠΎΠ³ΠΎ ΠΎΠΊΠΈΡΠ»Π΅Π½ΠΈΡ Π»ΠΈΠΏΠΈΠ΄ΠΎΠ² ΠΈ ΠΈΡΡΠΎΡΠ΅Π½ΠΈΠ΅ ΡΠ΅Π·Π΅ΡΠ²ΠΎΠ² Π°Π½ΡΠΈΠΎΠΊΡΠΈΠ΄Π°Π½ΡΠ½ΡΡ
ΡΠΈΡΡΠ΅ΠΌ. ΠΡΠΎ ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΡ ΠΊ Π³ΠΈΠΏΠ΅ΡΡΠ΅ΡΠΌΠ΅Π½ΡΠ΅ΠΌΠΈΠΈ (ΡΡΠΈΠ»Π΅Π½ΠΈΡ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΊΠ°ΡΠ΅ΠΏΡΠΈΠ½Π° Π, ΠΊΠΈΡΠ»ΠΎΠΉ ΡΠΎΡΡΠ°ΡΠ°Π·Ρ Π² ΡΠΊΠ°Π½ΡΡ
Π³ΠΎΠ»ΠΎΠ²Π½ΠΎΠ³ΠΎ ΠΌΠΎΠ·Π³Π° ΠΈ Π² ΠΊΡΠΎΠ²ΠΈ) ΠΈ Π½Π°ΠΊΠΎΠΏΠ»Π΅Π½ΠΈΡ ΡΠΎΠΊΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π²Π΅ΡΠ΅ΡΡΠ² (ΠΌΠΎΠ»Π΅ΠΊΡΠ» ΡΡΠ΅Π΄Π½Π΅ΠΉ ΠΌΠ°ΡΡΡ) Π² ΠΊΡΠΎΠ²ΠΈ (ΡΠΎΠΊΡΠ΅ΠΌΠΈΠΈ). ΠΠ»ΡΡΠ΅Π²ΡΠ΅ ΡΠ»ΠΎΠ²Π°: ΡΠΈΠ½Π΄ΡΠΎΠΌ ΠΏΠΎΡΡΡΡΠ°Π²ΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ½Π΄ΠΎΠ³Π΅Π½Π½ΠΎΠΉ ΠΈΠ½ΡΠΎΠΊΡΠΈΠΊΠ°ΡΠΈΠΈ, ΠΏΠ΅ΡΠ΅ΠΊΠΈΡΠ½ΠΎΠ΅ ΠΎΠΊΠΈΡΠ»Π΅Π½ΠΈΠ΅ Π»ΠΈΠΏΠΈΠ΄ΠΎΠ², ΡΠ΅ΡΠ΅ΠΏΠ½ΠΎ-ΠΌΠΎΠ·Π³ΠΎΠ²Π°Ρ ΡΡΠ°Π²ΠΌΠ°
Frequency of vaginal conditional-pathogenic microflora dependency from age in conditions of normocenosis and disbiosis
298 patients aged 16-64 years were examined who excluded the presence of
pathogenic microflora; Polymerase chain reaction (PCR) in real time investigated the
biocenosis of the vagina. Depending on the value of the index of opportunistic microflora, the
patients were divided into three groups: normocenosis, imbalance I and II degree (dysbiosis).
In each group age subgroups were distinguished: from 16 to 25 years, from 26 to 45 years and
over 45 years. It is shown that with age and with the increase in the degree of dysbiosis the
total bacterial mass and the population of the vagina decreased by lactobacilli. Normocenosis
is characterized by a constant occurrence of enterobacteria, an increase in the incidence of
candida with age, Eubacterium spp. And Mobiluncus spp. + Corynebacterium spp. In general,
Sneathia spp. + Leptotrihia spp. + Fusobacterium spp. And Mycoplasma hominis +
genitalium. With the 1st degree disbiosis the incidence of enterobacteria, Candida and
Ureaplasma urealiticum + parvum decreased with age, with more frequent occurrence of
staphylococci, Megasphaera spp. + Veilonella spp. + Dialister spp. Π°nd Lachnobacterium
spp. + Clostridium spp. The 2nd degree of dysbiosis was characterized by the disappearance of
streptococci with age and a decrease in the number of Eubacterium spp. (In patients older than 45 years), an increase in the frequency of obligate anaerobes, especially Mobiluncus spp.
+ Corynebacterium spp. and Atopobium vaginalis. Mycoplasma hominis + genitalium
appeared in the middle age group (26-45 years).ΠΠ±ΡΡΠ΅ΠΆΠ΅Π½ΠΎ 298 ΠΏΠ°ΡΡΡΠ½ΡΠΎΠΊ Π²ΡΠΊΠΎΠΌ Π²ΡΠ΄ 16 Π΄ΠΎ 64 ΡΠΎΠΊΡΠ², Ρ ΡΠΊΠΈΡ
Π²ΠΈΠΊΠ»ΡΡΠΈΠ»ΠΈ Π½Π°ΡΠ²Π½ΡΡΡΡ
ΠΏΠ°ΡΠΎΠ³Π΅Π½Π½ΠΎΡ ΠΌΡΠΊΡΠΎΡΠ»ΠΎΡΠΈ; ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΏΠΎΠ»ΡΠΌΠ΅ΡΠ°Π·Π½ΠΎΡ Π»Π°Π½ΡΡΠ³ΠΎΠ²ΠΎΡ ΡΠ΅Π°ΠΊΡΡΡ (ΠΠΠ ) in real time
Π΄ΠΎΡΠ»ΡΠ΄ΠΆΡΠ²Π°Π»ΠΈ Π±ΡΠΎΡΠ΅Π½ΠΎΠ· ΠΏΡΡ
Π²ΠΈ. ΠΠ°Π»Π΅ΠΆΠ½ΠΎ Π²ΡΠ΄ Π²Π΅Π»ΠΈΡΠΈΠ½ΠΈ ΡΠ½Π΄Π΅ΠΊΡΡ ΡΠΌΠΎΠ²Π½ΠΎ-ΠΏΠ°ΡΠΎΠ³Π΅Π½Π½ΠΎΡ
ΠΌΡΠΊΡΠΎΡΠ»ΠΎΡΠΈ ΠΏΠ°ΡΡΡΠ½ΡΠΎΠΊ ΡΠΎΠ·ΠΏΠΎΠ΄ΡΠ»ΠΈΠ»ΠΈ Π½Π° ΡΡΠΈ Π³ΡΡΠΏΠΈ: Π½ΠΎΡΠΌΠΎΡΠ΅Π½ΠΎΠ·, Π΄ΠΈΡΠ±Π°Π»Π°Π½Ρ I Ρ II ΡΡΡΠΏΠ΅Π½Ρ
(Π΄ΠΈΡΠ±ΡΠΎΠ·). Π£ ΠΊΠΎΠΆΠ½ΡΠΉ Π³ΡΡΠΏΡ Π±ΡΠ»ΠΈ Π²ΠΈΠ΄ΡΠ»Π΅Π½Ρ Π²ΡΠΊΠΎΠ²Ρ ΠΏΡΠ΄Π³ΡΡΠΏΠΈ: Π²ΡΠ΄ 16 Π΄ΠΎ 25 ΡΠΎΠΊΡΠ², Π²ΡΠ΄ 26 Π΄ΠΎ 45
ΡΠΎΠΊΡΠ² Ρ ΠΏΠΎΠ½Π°Π΄ 45 ΡΠΎΠΊΡΠ². ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΠΎ Π· Π²ΡΠΊΠΎΠΌ Ρ Π² ΠΌΡΡΡ Π·Π±ΡΠ»ΡΡΠ΅Π½Π½Ρ ΡΡΡΠΏΠ΅Π½Ρ Π΄ΠΈΡΠ±ΡΠΎΠ·Ρ
Π·Π½ΠΈΠΆΡΠ²Π°Π»Π°ΡΡ Π·Π°Π³Π°Π»ΡΠ½Π° Π±Π°ΠΊΡΠ΅ΡΡΠ°Π»ΡΠ½Π° ΠΌΠ°ΡΠ° Ρ Π·Π°ΡΠ΅Π»Π΅Π½ΡΡΡΡ ΠΏΡΡ
Π²ΠΈ Π»Π°ΠΊΡΠΎΠ±Π°ΠΊΡΠ΅ΡΡΡΠΌΠΈ. ΠΠ»Ρ
Π½ΠΎΡΠΌΠΎΡΠ΅Π½ΠΎΠ·Π° Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠ½Π° ΠΏΠΎΡΡΡΠΉΠ½Π° Π·ΡΡΡΡΡΡΠ°Π»ΡΠ½ΡΡΡΡ Π΅Π½ΡΠ΅ΡΠΎΠ±Π°ΠΊΡΠ΅ΡΡΠΉ, Π½Π°ΡΠΎΡΡΠ°Π½Π½Ρ Π· Π²ΡΠΊΠΎΠΌ
ΡΠ°ΡΡΠΎΡΠΈ Π½Π°ΡΠΎΠ΄ΠΆΠ΅Π½Π½Ρ ΠΊΠ°Π½Π΄ΠΈΠ΄, Eubacterium spp. Ρ Mobiluncus spp. + Corynebacterium spp.
ΠΠ·Π°Π³Π°Π»Ρ Π½Π΅ Π·ΡΡΡΡΡΡΠ°Π»ΠΈΡΡ Sneathia spp. + Leptotrihia spp. + Fusobacterium spp. Ρ
Mycoplasma hominis + genitalium. ΠΡΠΈ Π΄ΠΈΡΠ±ΠΈΠΎΠ·Π΅ I ΡΡΡΠΏΠ΅Π½Ρ Π· Π²ΡΠΊΠΎΠΌ Π·Π½ΠΈΠΆΡΠ²Π°Π»Π°ΡΡ ΡΠ°ΡΡΠΎΡΠ°
Π½Π°ΡΠΎΠ΄ΠΆΠ΅Π½Π½Ρ Π΅Π½ΡΠ΅ΡΠΎΠ±Π°ΠΊΡΠ΅ΡΡΠΉ, ΠΊΠ°Π½Π΄ΠΈΠ΄ Ρ Ureaplasma urealiticum + parvum, ΠΏΡΠΈ ΡΠ°ΡΡΡΡΠΎΡ
Π½Π°ΡΠΎΠ΄ΠΆΠ΅Π½Π½Ρ ΡΡΠ°ΡΡΠ»ΠΎΠΊΠΎΠΊΡΠ², Megasphaera spp. + Veilonella spp. + Dialister spp. Ρ
Lachnobacterium spp. + Clostridium spp. ΠΠΈΡΠ±ΡΠΎΠ· II ΡΡΡΠΏΠ΅Π½Ρ Π²ΡΠ΄ΡΡΠ·Π½ΡΠ²ΡΡ Π·Π½ΠΈΠΊΠ½Π΅Π½Π½ΡΠΌ Π·
Π²ΡΠΊΠΎΠΌ ΡΡΡΠ΅ΠΏΡΠΎΠΊΠΎΠΊΡΠ² Ρ Π·Π½ΠΈΠΆΠ΅Π½Π½ΡΠΌ ΡΠΈΡΠ»Π° Eubacterium spp. (Π£ ΠΏΠ°ΡΡΡΠ½ΡΠΎΠΊ ΡΡΠ°ΡΡΠ΅ 45 ΡΠΎΠΊΡΠ²),
Π·Π±ΡΠ»ΡΡΠ΅Π½Π½ΡΠΌ ΡΠ°ΡΡΠΎΡΠΈ Π²ΠΈΠ½ΠΈΠΊΠ½Π΅Π½Π½Ρ ΠΎΠ±Π»ΡΠ³Π°ΡΠ½ΠΈΡ
Π°Π½Π°Π΅ΡΠΎΠ±ΡΠ², ΠΎΡΠΎΠ±Π»ΠΈΠ²ΠΎ - Mobiluncus spp. +
Corynebacterium spp. Ρ Atopobium vaginalis. Π£ ΡΠ΅ΡΠ΅Π΄Π½ΡΠΉ Π²ΡΠΊΠΎΠ²ΡΠΉ Π³ΡΡΠΏΡ (26-45 ΡΠΎΠΊΡΠ²)
Π·'ΡΠ²Π»ΡΠ»ΠΈΡΡ Mycoplasma hominis + genitalium.ΠΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Ρ 298 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ ΠΎΡ 16 Π΄ΠΎ 64 Π»Π΅Ρ, Ρ ΠΊΠΎΡΠΎΡΡΡ
ΠΈΡΠΊΠ»ΡΡΠΈΠ»ΠΈ
Π½Π°Π»ΠΈΡΠΈΠ΅ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π½ΠΎΠΉ ΠΌΠΈΠΊΡΠΎΡΠ»ΠΎΡΡ; ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΏΠΎΠ»ΠΈΠΌΠ΅ΡΠ°Π·Π½ΠΎΠΉ ΡΠ΅ΠΏΠ½ΠΎΠΉ ΡΠ΅Π°ΠΊΡΠΈΠΈ (ΠΠ¦Π ) in real
time ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π»ΠΈ Π±ΠΈΠΎΡΠ΅Π½ΠΎΠ· Π²Π»Π°Π³Π°Π»ΠΈΡΠ°. Π Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ Π²Π΅Π»ΠΈΡΠΈΠ½Ρ ΠΈΠ½Π΄Π΅ΠΊΡΠ° ΡΡΠ»ΠΎΠ²Π½ΠΎΠΏΠ°ΡΠΎΠ³Π΅Π½Π½ΠΎΠΉ ΠΌΠΈΠΊΡΠΎΡΠ»ΠΎΡΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ ΡΠ°ΡΠΏΡΠ΅Π΄Π΅Π»ΠΈΠ»ΠΈ Π½Π° ΡΡΠΈ Π³ΡΡΠΏΠΏΡ: Π½ΠΎΡΠΌΠΎΡΠ΅Π½ΠΎΠ·,
Π΄ΠΈΡΠ±Π°Π»Π°Π½Ρ I ΠΈ II ΡΡΠ΅ΠΏΠ΅Π½ΠΈ (Π΄ΠΈΡΠ±ΠΈΠΎΠ·). Π ΠΊΠ°ΠΆΠ΄ΠΎΠΉ Π³ΡΡΠΏΠΏΠ΅ Π±ΡΠ»ΠΈ Π²ΡΠ΄Π΅Π»Π΅Π½Ρ Π²ΠΎΠ·ΡΠ°ΡΡΠ½ΡΠ΅
ΠΏΠΎΠ΄Π³ΡΡΠΏΠΏΡ: ΠΎΡ 16 Π΄ΠΎ 25 Π»Π΅Ρ, ΠΎΡ 26 Π΄ΠΎ 45 Π»Π΅Ρ ΠΈ Π±ΠΎΠ»Π΅Π΅ 45 Π»Π΅Ρ. ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ Ρ Π²ΠΎΠ·ΡΠ°ΡΡΠΎΠΌ ΠΈ
ΠΏΠΎ ΠΌΠ΅ΡΠ΅ ΡΡΡΠ³ΡΠ±Π»Π΅Π½ΠΈΡ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ Π΄ΠΈΡΠ±ΠΈΠΎΠ·Π° ΡΠ½ΠΈΠΆΠ°Π»Π°ΡΡ ΠΎΠ±ΡΠ°Ρ Π±Π°ΠΊΡΠ΅ΡΠΈΠ°Π»ΡΠ½Π°Ρ ΠΌΠ°ΡΡΠ° ΠΈ
Π·Π°ΡΠ΅Π»Π΅Π½Π½ΠΎΡΡΡ Π²Π»Π°Π³Π°Π»ΠΈΡΠ° Π»Π°ΠΊΡΠΎΠ±Π°ΠΊΡΠ΅ΡΠΈΡΠΌΠΈ. ΠΠ»Ρ Π½ΠΎΡΠΌΠΎΡΠ΅Π½ΠΎΠ·Π° Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠ½Π° ΠΏΠΎΡΡΠΎΡΠ½Π½Π°Ρ
Π²ΡΡΡΠ΅ΡΠ°Π΅ΠΌΠΎΡΡΡ ΡΠ½ΡΠ΅ΡΠΎΠ±Π°ΠΊΡΠ΅ΡΠΈΠΉ, Π½Π°ΡΠ°ΡΡΠ°Π½ΠΈΠ΅ Ρ Π²ΠΎΠ·ΡΠ°ΡΡΠΎΠΌ ΡΠ°ΡΡΠΎΡΡ Π²ΡΡΡΠ΅ΡΠ°Π΅ΠΌΠΎΡΡΠΈ ΠΊΠ°Π½Π΄ΠΈΠ΄,
Eubacterium spp. ΠΈ Mobiluncus spp.+Corynebacterium spp. ΠΠΎΠΎΠ±ΡΠ΅ Π½Π΅ Π²ΡΡΡΠ΅ΡΠ°Π»ΠΈΡΡ
Sneathia spp.+Leptotrihia spp.+Fusobacterium spp. ΠΈ Mycoplasma hominis+genitalium.
ΠΡΠΈ Π΄ΠΈΡΠ±ΠΈΠΎΠ·Π΅ I ΡΡΠ΅ΠΏΠ΅Π½ΠΈ Ρ Π²ΠΎΠ·ΡΠ°ΡΡΠΎΠΌ ΡΠ½ΠΈΠΆΠ°Π»Π°ΡΡ ΡΠ°ΡΡΠΎΡΠ° Π²ΡΡΡΠ΅ΡΠ°Π΅ΠΌΠΎΡΡΠΈ ΡΠ½ΡΠ΅ΡΠΎΠ±Π°ΠΊΡΠ΅ΡΠΈΠΉ,
ΠΊΠ°Π½Π΄ΠΈΠ΄ ΠΈ Ureaplasma urealiticum+parvum, ΠΏΡΠΈ Π±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΡΠΎΠΉ Π²ΡΡΡΠ΅ΡΠ°Π΅ΠΌΠΎΡΡΠΈ
ΡΡΠ°ΡΠΈΠ»ΠΎΠΊΠΎΠΊΠΊΠΎΠ², Megasphaera spp.+Veilonella spp.+Dialister spp. ΠΈ Lachnobacterium
spp.+Clostridium spp. ΠΠΈΡΠ±ΠΈΠΎΠ· II ΡΡΠ΅ΠΏΠ΅Π½ΠΈ ΠΎΡΠ»ΠΈΡΠ°Π»ΡΡ ΠΈΡΡΠ΅Π·Π½ΠΎΠ²Π΅Π½ΠΈΠ΅ΠΌ Ρ Π²ΠΎΠ·ΡΠ°ΡΡΠΎΠΌ
ΡΡΡΠ΅ΠΏΡΠΎΠΊΠΎΠΊΠΊΠΎΠ² ΠΈ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ΠΌ ΡΠΈΡΠ»Π° Eubacterium spp. (Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ ΡΡΠ°ΡΡΠ΅ 45 Π»Π΅Ρ),
ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ΠΌ ΡΠ°ΡΡΠΎΡΡ Π²ΡΡΡΠ΅ΡΠ°Π΅ΠΌΠΎΡΡΠΈ ΠΎΠ±Π»ΠΈΠ³Π°ΡΠ½ΡΡ
Π°Π½Π°ΡΡΠΎΠ±ΠΎΠ², ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎ β Mobiluncus
spp.+Corynebacterium spp. ΠΈ Atopobium vaginalis. Π ΡΡΠ΅Π΄Π½Π΅ΠΉ Π²ΠΎΠ·ΡΠ°ΡΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΠ΅(26-45
Π»Π΅Ρ) ΠΏΠΎΡΠ²Π»ΡΠ»ΠΈΡΡ Mycoplasma hominis+genitalium
Π ΠΎΠ»Ρ ΡΡΠ·Π½ΠΈΡ Π½ΡΠΊΠ»Π΅ΠΎΠ·ΠΈΠ΄ΡΠ² Π² Π°ΠΊΡΠΈΠ²Π°ΡΡΡ 5-ΡΡΠΎΡΡΡΠ°ΡΠΈΠ»Ρ ΠΏΡΠΈ Π°Π΄Π΅Π½ΠΎΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΡ ΡΠ»ΡΠ½ΠΊΠ°
The main metabolic pathways of anticancer drug 5-fluorouracil (5-FU) include its transformation to activemetabolites via attaching the naturally occurring pentose phosphates. It is known that different tissues use differentnucleosides as donators of pentose phosphates for activation of 5-FU. The objective of the present study wasdetermination of pentose phosphate sources for 5-FU metabolic transformation in gastric adenocarcinoma andnormal adjacent mucosa. 5-FU was incubated in vitro with one of the nucleosides (adenosine, uridine, thymidine)and tumor or adjacent tissue homogenates obtained from patients with gastric adenocarcinoma. The concentrationof initial metabolites and the products of the pentose exchange reaction in the samples was determined before andafter the incubation by means of HPLC . Both in systems with tumor and normal tissue homogenates the reactionof 2β-deoxyribose exchange between thymidine and 5-FU occurred resulting in equimolar production of 5-fluoro-2β-deoxyuridine and thymine. In the model system containing adenosine free ribose-1-phosphate was formed; however,the formation of nucleoside from 5-FU did not arise. It was also shown that mutual incubation of 5-FU and uridinewith gastric tissues homogenates did not result in the formation of 5-FUd. Among the examined natural nucleosidesit is only thymidine that serves as pentose phosphate source for the first step of the activation of 5-FU in gastricadenocarcinoma and normal adjacent tissue.ΠΡΠ½ΠΎΠ²Π½ΡΠ΅ ΠΏΡΡΠΈ Π±ΠΈΠΎΡΡΠ°Π½ΡΡΠΎΡΠΌΠ°ΡΠΈΠΈ ΠΏΡΠΎΡΠΈΠ²ΠΎΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΠΎΠ³ΠΎ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ° 5-ΡΡΠΎΡΡΡΠ°ΡΠΈΠ»Π° (5-Π€Π£) Π²ΠΊΠ»ΡΡΠ°ΡΡΒ Π΅Π³ΠΎ ΠΏΡΠ΅Π²ΡΠ°ΡΠ΅Π½ΠΈΠ΅ Π² Π°ΠΊΡΠΈΠ²Π½ΡΠ΅ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΡΡ ΠΏΡΡΠ΅ΠΌ ΠΏΡΠΈΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΡ Π΅ΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
ΠΏΠ΅Π½ΡΠΎΠ·ΠΎΡΠΎΡΡΠ°ΡΠΎΠ².ΠΠ·Π²Π΅ΡΡΠ½ΠΎ, ΡΡΠΎ Π² ΡΠ°Π·Π½ΡΡ
ΡΠΊΠ°Π½ΡΡ
ΡΠ°Π·Π½ΡΠ΅ Π½ΡΠΊΠ»Π΅ΠΎΠ·ΠΈΠ΄Ρ ΡΠ»ΡΠΆΠ°Ρ Π΄ΠΎΠ½ΠΎΡΠ°ΠΌΠΈ ΠΏΠ΅Π½ΡΠΎΠ·ΠΎΡΠΎΡΡΠ°ΡΠΎΠ² Π΄Π»Ρ Π°ΠΊΡΠΈΠ²Π°ΡΠΈΠΈΒ 5-Π€Π£. Π¦Π΅Π»ΡΡ ΡΡΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π±ΡΠ»ΠΎ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΠΈΡΡ ΠΈΡΡΠΎΡΠ½ΠΈΠΊΠΈ ΠΏΠ΅Π½ΡΠΎΠ·ΠΎΡΠΎΡΡΠ°ΡΠΎΠ², ΠΊΠΎΡΠΎΡΡΠ΅ ΠΈΡΠΏΠΎΠ»ΡΠ·ΡΡΡΡΡΠΊΠ»Π΅ΡΠΊΠ°ΠΌΠΈ Π°Π΄Π΅Π½ΠΎΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΡ ΠΈ Π½ΠΎΡΠΌΠ°Π»ΡΠ½ΠΎΠΉ ΡΠΌΠ΅ΠΆΠ½ΠΎΠΉ ΡΠ»ΠΈΠ·ΠΈΡΡΠΎΠΉ ΠΎΠ±ΠΎΠ»ΠΎΡΠΊΠΈ ΠΆΠ΅Π»ΡΠ΄ΠΊΠ° Π΄Π»Ρ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡΠ°Π½Ρ-ΡΠΎΡΠΌΠ°ΡΠΈΠΈ 5-Π€Π£. ΠΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ ΠΈΠ½ΠΊΡΠ±Π°ΡΠΈΡ 5-Π€Π£ Ρ ΠΎΠ΄Π½ΠΈΠΌ ΠΈΠ· Π½ΡΠΊΠ»Π΅ΠΎΠ·ΠΈΠ΄ΠΎΠ² (Π°Π΄Π΅Π½ΠΎΠ·ΠΈΠ½ΠΎΠΌ, ΡΠΈΠΌΠΈΠ΄ΠΈΠ½ΠΎΠΌ ΠΈ ΡΡΠΈΠ΄ΠΈΠ½ΠΎΠΌ)in vitro ΠΏΡΠΈ Π΄ΠΎΠ±Π°Π²Π»Π΅Π½ΠΈΠΈ Π³ΠΎΠΌΠΎΠ³Π΅Π½Π°ΡΠ° ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΠΎΠΉ ΠΈΠ»ΠΈ ΡΠΌΠ΅ΠΆΠ½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
ΠΎΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π°Π΄Π΅Π½ΠΎΠΊΠ°Ρ-ΡΠΈΠ½ΠΎΠΌΠΎΠΉ ΠΆΠ΅Π»ΡΠ΄ΠΊΠ°. ΠΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡ ΠΈΡΡ
ΠΎΠ΄Π½ΡΡ
Π²Π΅ΡΠ΅ΡΡΠ² ΠΈ ΠΏΡΠΎΠ΄ΡΠΊΡΠΎΠ² ΡΠ΅Π°ΠΊΡΠΈΠΈ ΠΎΠ±ΠΌΠ΅Π½Π° ΠΏΠ΅Π½ΡΠΎΠ·ΠΎΡΠΎΡΡΠ°ΡΠ°ΠΌΠΈΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»ΠΈ Π΄ΠΎ ΠΈ ΠΏΠΎΡΠ»Π΅ ΠΈΠ½ΠΊΡΠ±Π°ΡΠΈΠΈ ΠΏΡΠΎΠ± ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΠΠ Π₯. ΠΠ°ΠΊ Π² ΡΠΈΡΡΠ΅ΠΌΠ΅ ΠΈΠ· Π³ΠΎΠΌΠΎΠ³Π΅Π½Π°ΡΠΎΠΌ ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ,Β ΡΠ°ΠΊ ΠΈ Π² ΡΠΈΡΡΠ΅ΠΌΠ΅ Ρ Π½ΠΎΡΠΌΠ°Π»ΡΠ½ΠΎΠΉ ΡΠ»ΠΈΠ·ΠΈΡΡΠΎΠΉ ΠΎΠ±ΠΎΠ»ΠΎΡΠΊΠΎΠΉ ΠΆΠ΅Π»ΡΠ΄ΠΊΠ° ΠΏΡΠΎΠΈΡΡ
ΠΎΠ΄ΠΈΠ»Π° ΡΠ΅Π°ΠΊΡΠΈΡ ΠΎΠ±ΠΌΠ΅Π½Π° 2β-Π΄Π΅Π·ΠΎΠΊΡΠΈΡΠΈΠ±ΠΎΠ·ΠΎ-1-ΡΠΎΡΡΠ°ΡΠΎΠΌ ΠΌΠ΅ΠΆΠ΄Ρ ΡΠΈΠΌΠΈΠ΄ΠΈΠ½ΠΎΠΌ ΠΈ 5-Π€Π£, ΠΊΠΎΡΠΎΡΠ°Ρ ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΠ»Π° ΠΊ ΡΠΊΠ²ΠΈΠΌΠΎΠ»ΡΡΠ½ΠΎΠΌΡ ΠΏΡΠΈΡΠΎΡΡΡ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈΒ 5-ΡΡΠΎΡ-2β-Π΄Π΅Π·ΠΎΠΊΡΠΈΡΡΠΈΠ΄ΠΈΠ½Π° ΠΈ ΡΠΈΠΌΠΈΠ½Π°. Π ΠΌΠΎΠ΄Π΅Π»ΡΠ½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΠ΅, ΠΊΠΎΡΠΎΡΠ°Ρ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π»Π° Π°Π΄Π΅Π½ΠΎΠ·ΠΈΠ½, ΠΎΠ±ΡΠ°Π·ΠΎΠ²ΡΠ²Π°Π»ΡΡΡΠ²ΠΎΠ±ΠΎΠ΄Π½ΡΠΉ ΡΠΈΠ±ΠΎΠ·ΠΎ-1-ΡΠΎΡΡΠ°Ρ, ΠΎΠ΄Π½Π°ΠΊΠΎ ΠΏΡΠΈ ΡΡΠΎΠΌ Π½Π΅ Π½Π°Π±Π»ΡΠ΄Π°Π»ΠΈ ΠΏΡΠ΅Π²ΡΠ°ΡΠ΅Π½ΠΈΡ 5-Π€Π£ Π² Π½ΡΠΊΠ»Π΅ΠΎΠ·ΠΈΠ΄. ΠΡΠΈ ΡΠΎΠ²ΠΌΠ΅ΡΡ-Π½ΠΎΠΉ ΠΈΠ½ΠΊΡΠ±Π°ΡΠΈΠΈ 5-Π€Π£ Ρ ΡΡΠΈΠ΄ΠΈΠ½ΠΎΠΌ ΠΈ Π³ΠΎΠΌΠΎΠ³Π΅Π½Π°ΡΠ°ΠΌΠΈ ΡΠΊΠ°Π½Π΅ΠΉ ΠΆΠ΅Π»ΡΠ΄ΠΊΠ° Π½Π΅ ΠΏΡΠΎΠΈΡΡ
ΠΎΠ΄ΠΈΠ»ΠΎ ΡΠΈΠ½ΡΠ΅Π·Π° 5-ΡΡΠΎΡΡΡΠΈΠ΄ΠΈΠ½Π°.Π‘ΡΠ΅Π΄ΠΈ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Π½ΡΡ
Π΅ΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
Π½ΡΠΊΠ»Π΅ΠΎΠ·ΠΈΠ΄ΠΎΠ² Π»ΠΈΡΡ ΡΠΈΠΌΠΈΠ΄ΠΈΠ½ ΡΠ»ΡΠΆΠΈΡ ΠΈΡΡΠΎΡΠ½ΠΈΠΊΠΎΠΌ ΠΏΠ΅Π½ΡΠΎΠ·ΠΎΡΠΎΡΡΠ°ΡΠ°Β Π΄Π»Ρ ΠΏΠ΅ΡΠ²ΠΎΠ³ΠΎ ΡΡΠ°ΠΏΠ° Π°ΠΊΡΠΈΠ²Π°ΡΠΈΠΈ 5-Π€Π£ Π² Π°Π΄Π΅Π½ΠΎΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΠ΅ ΠΈ Π½ΠΎΡΠΌΠ°Π»ΡΠ½ΠΎΠΉ ΡΠ»ΠΈΠ·ΠΈΡΡΠΎΠΉ ΠΎΠ±ΠΎΠ»ΠΎΡΠΊΠ΅ ΠΆΠ΅Π»ΡΠ΄ΠΊΠ°.ΠΡΠ½ΠΎΠ²Π½Ρ ΡΠ»ΡΡ
ΠΈ Π±ΡΠΎΡΡΠ°Π½ΡΡΠΎΡΠΌΠ°ΡΡΡ ΠΏΡΠΎΡΠΈΠΏΡΡ
Π»ΠΈΠ½Π½ΠΎΠ³ΠΎ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΡ 5-ΡΡΠΎΡΡΡΠ°ΡΠΈΠ»Ρ (5-Π€Π£) Π²ΠΊΠ»ΡΡΠ°ΡΡΡ ΠΉΠΎΠ³ΠΎΠΏΠ΅ΡΠ΅ΡΠ²ΠΎΡΠ΅Π½Π½Ρ Π½Π° Π°ΠΊΡΠΈΠ²Π½Ρ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΡΡΠΈ ΡΠ»ΡΡ
ΠΎΠΌ ΠΏΡΠΈΡΠ΄Π½Π°Π½Π½Ρ ΠΏΡΠΈΡΠΎΠ΄Π½ΠΈΡ
ΠΏΠ΅Π½ΡΠΎΠ·ΠΎΡΠΎΡΡΠ°ΡΡΠ². ΠΡΠ΄ΠΎΠΌΠΎ, ΡΠΎ Π²ΡΡΠ·Π½ΠΈΡ
ΡΠΊΠ°Π½ΠΈΠ½Π°Ρ
ΡΡΠ·Π½Ρ Π½ΡΠΊΠ»Π΅ΠΎΠ·ΠΈΠ΄ΠΈ ΡΠ»ΡΠ³ΡΡΡΡ Π΄ΠΎΠ½ΠΎΡΠ°ΠΌΠΈ ΠΏΠ΅Π½ΡΠΎΠ·ΠΎΡΠΎΡΡΠ°ΡΡΠ² Π΄Π»Ρ Π°ΠΊΡΠΈΠ²Π°ΡΡΡ 5-Π€Π£. ΠΠ΅ΡΠΎΡ ΡΡΠΎΠ³ΠΎΠ΄ΠΎΡΠ»ΡΠ΄ΠΆΠ΅Π½Π½Ρ Π±ΡΠ»ΠΎ Π²ΠΈΠ·Π½Π°ΡΠΈΡΠΈ Π΄ΠΆΠ΅ΡΠ΅Π»Π° ΠΏΠ΅Π½ΡΠΎΠ·ΠΎΡΠΎΡΡΠ°ΡΡΠ², ΡΠΊΡ Π²ΠΈΠΊΠΎΡΠΈΡΡΠΎΠ²ΡΡΡΡΡΡ ΠΊΠ»ΡΡΠΈΠ½Π°ΠΌΠΈ Π°Π΄Π΅Π½ΠΎΠΊΠ°ΡΡΠΈ-Π½ΠΎΠΌΠΈ ΡΠ° Π½ΠΎΡΠΌΠ°Π»ΡΠ½ΠΎΡ ΡΡΠΌΡΠΆΠ½ΠΎΡ ΡΠ»ΠΈΠ·ΠΎΠ²ΠΎΡ ΠΎΠ±ΠΎΠ»ΠΎΠ½ΠΊΠΈ ΡΠ»ΡΠ½ΠΊΠ° Π΄Π»Ρ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΡΡΠ½ΠΎΡ ΡΡΠ°Π½ΡΡΠΎΡΠΌΠ°ΡΡΡ 5-Π€Π£. ΠΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈΡΠ½ΠΊΡΠ±Π°ΡΡΡ 5-Π€Π£ Π· ΠΎΠ΄Π½ΠΈΠΌ ΡΠ· Π½ΡΠΊΠ»Π΅ΠΎΠ·ΠΈΠ΄ΡΠ² (Π°Π΄Π΅Π½ΠΎΠ·ΠΈΠ½ΠΎΠΌ, ΡΠΈΠΌΡΠ΄ΠΈΠ½ΠΎΠΌ ΡΠ° ΡΡΠΈΠ΄ΠΈΠ½ΠΎΠΌ) in vitro ΠΏΡΠΈ Π΄ΠΎΠ΄Π°Π²Π°Π½Π½Ρ Π³ΠΎΠΌΠΎΠ³Π΅Π½Π°ΡΡΠΏΡΡ
Π»ΠΈΠ½Π½ΠΎΡ Π°Π±ΠΎ ΡΡΠΌΡΠΆΠ½ΠΎΡ ΡΠΊΠ°Π½ΠΈΠ½ΠΈ, ΠΎΡΡΠΈΠΌΠ°Π½ΠΈΡ
Π²ΡΠ΄ ΠΏΠ°ΡΡΡΠ½ΡΡΠ² Π· Π°Π΄Π΅Π½ΠΎΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΠΎΡ ΡΠ»ΡΠ½ΠΊΠ°. ΠΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΡΡΠ²ΠΈΡ
ΡΠ΄Π½ΠΈΡ
ΡΠ΅ΡΠΎΠ²ΠΈΠ½ ΡΠ° ΠΏΡΠΎΠ΄ΡΠΊΡΡΠ² ΡΠ΅Π°ΠΊΡΡΡ ΠΎΠ±ΠΌΡΠ½Ρ ΠΏΠ΅Π½ΡΠΎΠ·ΠΎΡΠΎΡΡΠ°ΡΠ°ΠΌΠΈ Π²ΠΈΠ·Π½Π°ΡΠ°Π»ΠΈ Π΄ΠΎ Ρ ΠΏΡΡΠ»Ρ ΡΠ½ΠΊΡΠ±Π°ΡΡΡ ΠΏΡΠΎΠ±ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΠΠ Π₯. Π―ΠΊ Ρ ΡΠΈΡΡΠ΅ΠΌΡ Π· Π³ΠΎΠΌΠΎΠ³Π΅Π½Π°ΡΠΎΠΌ ΠΏΡΡ
Π»ΠΈΠ½Π½ΠΎΡ ΡΠΊΠ°Π½ΠΈΠ½ΠΈ, ΡΠ°ΠΊ Ρ Π² ΡΠΈΡΡΠ΅ΠΌΡ Π· Π½ΠΎΡΠΌΠ°Π»ΡΠ½ΠΎΡ ΡΠ»ΠΈΠ·ΠΎΠ²ΠΎΡΠΎΠ±ΠΎΠ»ΠΎΠ½ΠΊΠΎΡ ΡΠ»ΡΠ½ΠΊΠ° Π²ΡΠ΄Π±ΡΠ²Π°Π»Π°ΡΡ ΡΠ΅Π°ΠΊΡΡΡ ΠΎΠ±ΠΌΡΠ½Ρ 2β-Π΄Π΅Π·ΠΎΠΊΡΠΈΡΠΈΠ±ΠΎΠ·ΠΎ-1-ΡΠΎΡΡΠ°ΡΠΎΠΌ ΠΌΡΠΆ ΡΠΈΠΌΡΠ΄ΠΈΠ½ΠΎΠΌ Ρ 5-Π€Π£, ΡΠΊΠ°ΠΏΡΠΈΠ·Π²ΠΎΠ΄ΠΈΠ»Π° Π΄ΠΎ Π΅ΠΊΠ²ΡΠΌΠΎΠ»ΡΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΈΡΠΎΡΡΡ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΡΡ 5-ΡΡΠΎΡ-2β-Π΄Π΅Π·ΠΎΠΊΡΠΈΡΡΠΈΠ΄ΠΈΠ½Ρ ΡΠ° ΡΠΈΠΌΡΠ½Ρ. Π ΠΌΠΎΠ΄Π΅Π»ΡΠ½ΡΠΉΡΠΈΡΡΠ΅ΠΌΡ, ΡΠΊΠ° ΠΌΡΡΡΠΈΠ»Π° Π°Π΄Π΅Π½ΠΎΠ·ΠΈΠ½, ΡΡΠ²ΠΎΡΡΠ²Π°Π²ΡΡ Π²ΡΠ»ΡΠ½ΠΈΠΉ ΡΠΈΠ±ΠΎΠ·ΠΎ-1-ΡΠΎΡΡΠ°Ρ, ΠΎΠ΄Π½Π°ΠΊ ΠΏΡΠΈ ΡΡΠΎΠΌΡ Π½Π΅ ΡΠΏΠΎΡΡΠ΅ΡΡΠ³Π°Π»ΠΈΠΏΠ΅ΡΠ΅ΡΠ²ΠΎΡΠ΅Π½Π½Ρ 5-Π€Π£ Π½Π° Π½ΡΠΊΠ»Π΅ΠΎΠ·ΠΈΠ΄. ΠΡΠΈ ΡΡΠΌΡΡΠ½ΡΠΉ ΡΠ½ΠΊΡΠ±Π°ΡΡΡ 5-Π€Π£ Π· ΡΡΠΈΠ΄ΠΈΠ½ΠΎΠΌ ΡΠ° Π³ΠΎΠΌΠΎΠ³Π΅Π½Π°ΡΠ°ΠΌΠΈ ΡΠΊΠ°Π½ΠΈΠ½ ΡΠ»ΡΠ½ΠΊΠ°Π½Π΅ Π²ΡΠ΄Π±ΡΠ²Π°Π»ΠΎΡΡ ΡΠΈΠ½ΡΠ΅Π·Ρ 5-ΡΡΠΎΡΡΡΠΈΠ΄ΠΈΠ½Ρ. Π‘Π΅ΡΠ΅Π΄ Π΄ΠΎΡΠ»ΡΠ΄ΠΆΠ΅Π½ΠΈΡ
ΠΏΡΠΈΡΠΎΠ΄Π½ΠΈΡ
Π½ΡΠΊΠ»Π΅ΠΎΠ·ΠΈΠ΄ΡΠ² Π»ΠΈΡΠ΅ ΡΠΈΠΌΡΠ΄ΠΈΠ½ ΡΠ»ΡΠ³ΡΡΠ΄ΠΆΠ΅ΡΠ΅Π»ΠΎΠΌ ΠΏΠ΅Π½ΡΠΎΠ·ΠΎΡΠΎΡΡΠ°ΡΡ Π΄Π»Ρ ΠΏΠ΅ΡΡΠΎΠ³ΠΎ Π΅ΡΠ°ΠΏΡ Π°ΠΊΡΠΈΠ²Π°ΡΡΡ 5-Π€Π£ Π² Π°Π΄Π΅Π½ΠΎΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΡ ΡΠ° Π½ΠΎΡΠΌΠ°Π»ΡΠ½ΡΠΉ ΡΠ»ΠΈΠ·ΠΎΠ²ΡΠΉΠΎΠ±ΠΎΠ»ΠΎΠ½ΡΡ ΡΠ»ΡΠ½ΠΊΠ°
Information features laboratory information system Β«UraniumΒ»
Determined the importance of the implementation of laboratory information system in the laboratory, the main principles of information on the characteristics of the laboratory information system Β«URANIUMΒ»
Frequency of vaginal conditional-pathogenic microflora dependency from age in conditions of normocenosis and disbiosis
298 patients aged 16-64 years were examined who excluded the presence of pathogenic microflora; Polymerase chain reaction (PCR) in real time investigated the biocenosis of the vagina. Depending on the value of the index of opportunistic microflora, the patients were divided into three groups: normocenosis, imbalance I and II degree (dysbiosis). In each group age subgroups were distinguished: from 16 to 25 years, from 26 to 45 years and over 45 years. It is shown that with age and with the increase in the degree of dysbiosis the total bacterial mass and the population of the vagina decreased by lactobacilli. Normocenosis is characterized by a constant occurrence of enterobacteria, an increase in the incidence of candida with age, Eubacterium spp. And Mobiluncus spp. + Corynebacterium spp. In general, Sneathia spp. + Leptotrihia spp. + Fusobacterium spp. And Mycoplasma hominis + genitalium. With the 1st degree disbiosis the incidence of enterobacteria, Candida and Ureaplasma urealiticum + parvum decreased with age, with more frequent occurrence of staphylococci, Megasphaera spp. + Veilonella spp. + Dialister spp. Π°nd Lachnobacterium spp. + Clostridium spp. The 2nd degree of dysbiosis was characterized by the disappearance of streptococci with age and a decrease in the number of Eubacterium spp. (In patients older than 45 years), an increase in the frequency of obligate anaerobes, especially Mobiluncus spp. + Corynebacterium spp. and Atopobium vaginalis. Mycoplasma hominis + genitalium appeared in the middle age group (26-45 years)